59 related articles for article (PubMed ID: 94871)
21. [The antithrombotic treatment and prevention of recurrence with acetylsalicylic acid in myocardial infarct].
Heuchel G; Hässler W
Z Gesamte Inn Med; 1976 Feb; 31(3):61-5. PubMed ID: 1085534
[TBL] [Abstract][Full Text] [Related]
22. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
23. Anti-thrombotic drugs in the treatment of coronary heart disease: the present situation with aspirin.
Born GV
Z Kardiol; 1990; 79 Suppl 3():147-50. PubMed ID: 2099037
[TBL] [Abstract][Full Text] [Related]
24. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Lubsen J
Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
[No Abstract] [Full Text] [Related]
25. Superior prevention of reinfarction by 30 mg per day aspirin compared with 1000 mg: results of a two years follow-up study in Cottbus.
Förster W; Hoffmann W
Prog Clin Biol Res; 1989; 301():187-91. PubMed ID: 2798445
[TBL] [Abstract][Full Text] [Related]
26. [Secondary prevention after myocardial infarction--beta blockade and acetylsalicylic acid is the basic therapy].
Bergstrand R; Johansson S; Ulvenstam G; Aberg A; Wilhelmsen L
Lakartidningen; 1989 Jan; 86(1-2):47-50. PubMed ID: 2562999
[No Abstract] [Full Text] [Related]
27. Secondary prevention of myocardial reinfarction with low dose aspirin.
Chen Z; Xu Y; Yu Q; Kou W; Lu Z; Yao K; Gao R; Chen J; Jia Y; Duan B
Chin Med Sci J; 1991 Sep; 6(3):141-4. PubMed ID: 1793876
[TBL] [Abstract][Full Text] [Related]
28. A multicenter study on timolol in secondary prevention after myocardial infarction.
Acta Med Scand Suppl; 1983; 674():1-129. PubMed ID: 6580807
[TBL] [Abstract][Full Text] [Related]
29. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
[TBL] [Abstract][Full Text] [Related]
30. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
31. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
Circulation; 1980 Dec; 62(6 Pt 2):V79-84. PubMed ID: 7438383
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
Bartolucci AA; Howard G
Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
[TBL] [Abstract][Full Text] [Related]
33. Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study.
Kjeldsen SE; Warnold I; Hansson L;
J Gend Specif Med; 2000; 3(8):35-8. PubMed ID: 11253266
[TBL] [Abstract][Full Text] [Related]
34. Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction.
Verheugt FW; van der Laarse A; Funke-Küpper AJ; Sterkman LG; Galema TW; Roos JP
Am J Cardiol; 1990 Aug; 66(3):267-70. PubMed ID: 2195861
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.
Elwood PC; Cochrane AL; Burr ML; Sweetnam PM; Williams G; Welsby E; Hughes SJ; Renton R
Br Med J; 1974 Mar; 1(5905):436-40. PubMed ID: 4593555
[TBL] [Abstract][Full Text] [Related]
36. [Cost-effectiveness analysis of prevention of reinfarction using low-dose acetylsalicylic acid; model calculation].
Schädlich PK; Brecht JG
Soz Praventivmed; 1997; 42(2):114-20. PubMed ID: 9221624
[TBL] [Abstract][Full Text] [Related]
37. Editorial: aspirin and myocardial infarction: a new national cooperative trial.
JAMA; 1975 Jun; 232(13):1359-60. PubMed ID: 1094140
[No Abstract] [Full Text] [Related]
38. Trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction.
Elwood P
Br Med J (Clin Res Ed); 1981 Feb; 282(6262):481. PubMed ID: 6780093
[No Abstract] [Full Text] [Related]
39. Anturane reinfarction trial.
Evans DW
Lancet; 1978 Aug; 2(8085):366-7. PubMed ID: 79725
[No Abstract] [Full Text] [Related]
40. A controlled study of prednisone, aspirin and a placebo in degenerative joint disease.
WILLIAMS GT; WELCH GE
South Med J; 1957 Aug; 50(8):1063-4. PubMed ID: 13455093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
